The AHA today submitted a letter to the Office of Science and Technology Policy in response to its request for information on regulatory reform for artificial intelligence, emphasizing the need to reduce regulatory burdens that hinder innovation and increase costs, while ensuring patient safety and data privacy. The letter outlines four key recommendations: synchronizing AI policies with existing frameworks to avoid redundancy, removing regulatory barriers such as fragmented privacy laws and outdated substance use disorder regulations, ensuring safe and effective AI use through clinician involvement in decision loops that impact care delivery and consistent standards for third-party vendors, and addressing organizational and infrastructural challenges by aligning incentives and investing in digital access and literacy. The AHA encourages OSTP to ensure balanced, flexible policies that support innovation and improve care delivery across the health system. 

Headline
The Federal Trade Commission announced Sept. 9 that it rescinded its 2021 policy statement that extended applicability of its health breach notification rule…
Headline
In this conversation, John Riggi, AHA national advisor for cybersecurity and risk, and Scott Gee, AHA deputy national advisor for cybersecurity and risk, break…
Headline
The AHA has released a fact sheet explaining how artificial intelligence tools help alleviate administrative burden for providers, particularly in areas such…
Headline
The Food and Drug Administration is seeking public feedback on a discussion paper released today on potential regulatory approaches for generative artificial…
Headline
The AHA Aug. 13 responded to a Food and Drug Administration request for input on the risks and benefits to health and safety associated with non-device…
Headline
The Common Health Coalition announced Aug. 13 that it will receive $100 million in funding from the OpenAI Foundation for a new initiative using artificial…